Literature DB >> 26384165

Validation of Concentric Rings Method as a Topographic Measure of Retinal Nonperfusion in Ultra-Widefield Fluorescein Angiography.

Luke Nicholson1, Clara Vazquez-Alfageme1, Jayashree Ramu1, Ioanna Triantafyllopoulou1, Namritha V Patrao1, Mahdi Muwas1, Farrah Islam1, Philip G Hykin1, Sobha Sivaprasad2.   

Abstract

PURPOSE: To validate the use of concentric rings as a method to measure topographic area of retinal nonperfusion in ultra-widefield angiography with the ischemic index method, which is the most frequently used method to measure nonperfusion in ultra-widefield angiography.
DESIGN: Validation study and reliability analysis.
METHODS: setting: Single-center study performed at National Institute for Health Research Moorfields Biomedical Research Centre, London, United Kingdom. STUDY POPULATION: Twenty-eight ultra-widefield angiogram images of eyes with central retinal vein occlusion. OBSERVATION PROCEDURE: The concentric rings method consists of 6 macula-centered concentric rings divided into 12 segments each. Each image was graded by 5 graders using both the concentric rings and the ischemic index methods. MAIN OUTCOME MEASURES: Agreement between the 2 methods was calculated using the intraclass correlation coefficient. Intertest agreement, intergrader agreement, test-retest reliability, and the time taken to grade using these 2 methods were compared.
RESULTS: The intertest agreement between concentric rings method and ischemic index method was 0.965. The intergrader agreement was 0.910 for the concentric rings method and 0.898 with the ischemic index method. The test-retest reliability was 0.975 for the rings and 0.979 for the ischemic index. Average grading time per image was 187 s and 297 s for the concentric rings method and ischemic index method, respectively, P < .001.
CONCLUSION: The concentric rings method has an "almost-perfect" intergrader agreement and intertest agreement with the ischemic index method, with a shorter grading time.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26384165     DOI: 10.1016/j.ajo.2015.09.003

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  Structural and functional changes to the retina and optic nerve following panretinal photocoagulation over a 2-year time period.

Authors:  R Filek; P Hooper; T Sheidow; J Gonder; D K Varma; L Heckler; W Hodge; S Chakrabarti; C M L Hutnik
Journal:  Eye (Lond)       Date:  2017-04-28       Impact factor: 3.775

2.  Quantitative analysis of retinal vasculature in normal eyes using ultra-widefield fluorescein angiography.

Authors:  Jing-Wen Jiang; Zuo-Hui-Zi Yi; Xiao-Ling Wang; Jue-Jun Liu; Gong-Peng Sun; Chang-Zheng Chen
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

3.  [Ultra-widefield angiography for retinal vein occlusion : How large is large enough?]

Authors:  M Storch; S Bemme; M Rehak; H Hoerauf; N Feltgen
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

4.  Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Authors:  Philip Hykin; A Toby Prevost; Sobha Sivaprasad; Joana C Vasconcelos; Caroline Murphy; Joanna Kelly; Jayashree Ramu; Abualbishr Alshreef; Laura Flight; Rebekah Pennington; Barry Hounsome; Ellen Lever; Andrew Metry; Edith Poku; Yit Yang; Simon P Harding; Andrew Lotery; Usha Chakravarthy; John Brazier
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

5.  Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.

Authors:  Luke Nicholson; Jayashree Ramu; Errol W Chan; James W Bainbridge; Philip G Hykin; Stephen J Talks; Sobha Sivaprasad
Journal:  JAMA Ophthalmol       Date:  2019-06-01       Impact factor: 7.389

6.  Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab.

Authors:  Kerr Brogan; Monica Precup; Amanda Rodger; David Young; David Francis Gilmour
Journal:  BMC Ophthalmol       Date:  2018-02-09       Impact factor: 2.209

7.  The clinical relevance of ultra-widefield angiography findings in patients with central retinal vein occlusion and macular oedema receiving anti-VEGF therapy.

Authors:  Luke Nicholson; Clara Vazquez-Alfageme; Piyali Sen; Namritha V Patrao; Tunde Peto; Yit Yang; Sobha Sivaprasad; Philip G Hykin
Journal:  Eye (Lond)       Date:  2021-05-25       Impact factor: 4.456

8.  ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION.

Authors:  Sophie Bonnin; Bénédicte Dupas; Carlo Lavia; Ali Erginay; Myriam Dhundass; Aude Couturier; Alain Gaudric; Ramin Tadayoni
Journal:  Retina       Date:  2019-03       Impact factor: 4.256

Review 9.  Ultra-widefield retinal imaging: an update on recent advances.

Authors:  Samir N Patel; Angell Shi; Turner D Wibbelsman; Michael A Klufas
Journal:  Ther Adv Ophthalmol       Date:  2020-01-20

10.  Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy.

Authors:  Luke Nicholson; Roxanne Crosby-Nwaobi; Joana C Vasconcelos; A Toby Prevost; Jayashree Ramu; Amy Riddell; James W Bainbridge; Philip G Hykin; Sobha Sivaprasad
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.